Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants von Beyhaghi, Hadi, MD, MPH, Reeve, Bryce B., PhD, Rodgers, Jo E., PharmD, Stearns, Sally C., PhD

Volltext

Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline Directed Medical Therapy of Heart Failure von Rodgers, Jo E., PharmD, BCPS-AQ Cardiology, FCCP, FHFSA, FAHA, Clinical Associate Professor, Associate Director, Clinical Fellowship Programs

Volltext

Heart transplantation and human immunodeficiency virus-navigating drug-drug interactions: a case report von Almangour, Thamer A, Skersick, Preston T, Corbett, Amanda, Rodgers, Jo E, Chang, Patricia P, Farel, Claire E

Volltext

Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study) von Sueta, Carla A., MD, Rodgers, Jo E., PharmD, Chang, Patricia P., MD, Zhou, Lei, MSPH, Thudium, Emily M., PharmD, Kucharska-Newton, Anna M., PhD, Stearns, Sally C., PhD

Volltext

Acute Decompensated Heart Failure Update von Teerlink, John R, Alburikan, Khalid, Metra, Marco, Rodgers, Jo E

Volltext

Disparities by sex in P2Y12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men... von Hickson, Ryan P, Kucharska-Newton, Anna M, Rodgers, Jo E, Sleath, Betsy L, Fang, Gang

Volltext

Optimal P2Y12 inhibitor durations in older men and older women following an acute myocardial infarction: A nationwide cohort study using Medicare data von Hickson, Ryan P., Kucharska-Newton, Anna M., Rodgers, Jo E., Sleath, Betsy L., Fang, Gang

Volltext

Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association von Beavers, Craig J., Rodgers, Jo E., Bagnola, Aaron J., Beckie, Theresa M., Campia, Umberto, Di Palo, Katherine E., Okwuosa, Tochi M., Przespolewski, Eugene R., Dent, Susan

Volltext

Continuous Versus Intermittent Infusion of Furosemide in Acute Decompensated Heart Failure von Thomson, Margaret R., PharmD, BCPS, Nappi, Jean M., PharmD, BCPS, Dunn, Steven P., PharmD, BCPS, Hollis, Ian B., PharmD, BCPS, Rodgers, Jo E., PharmD, BCPS, Van Bakel, Adrian B., MD, PhD

Volltext

Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer von Lam, Brian, Rodgers, Jo E., Muluneh, Benyam, Proco, Darrian, Whang, Young E., Morgan, Katherine P.

Volltext

Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure von Casey, Martin F., Hallmark, Joy, Chang, Patricia P., Rodgers, Jo E., Mehta, Aakash, Chari, Srihari V., Skersick, Preston, Bohrmann, Thomas, Goyal, Parag, Meyer, Michelle L.

Volltext

Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation von Cox, Christopher E, Reed, Shelby D, Govert, Joseph A, Rodgers, Jo E, Campbell-Bright, Stacy, Kress, John P, Carson, Shannon S

Volltext

Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee von Fang, James C., MD, Ewald, Gregory A., MD, Allen, Larry A., MD, MHS, Butler, Javed, MD, Westlake Canary, Cheryl A., RN, PhD, Colvin-Adams, Monica, MD, Dickinson, Michael G., MD, Levy, Phillip, MD, MPH, Stough, Wendy Gattis, PharmD, Sweitzer, Nancy K., MD, PhD, Teerlink, John R., MD, Whellan, David J., MD, MHS, Albert, Nancy M., RN, PhD, Krishnamani, Rajan, MD, Rich, Michael W., MD, Walsh, Mary N., MD, Bonnell, Mark R., MD, Carson, Peter E., MD, Chan, Michael C., MBBS, Dries, Daniel L., MD, Hernandez, Adrian F., MD, Hershberger, Ray E., MD, Katz, Stuart D., MD, Moore, Stephanie, MD, Rodgers, Jo E., PharmD, Rogers, Joseph G., MD, Vest, Amanda R., MBBS, Givertz, Michael M., MD

Volltext

Maintaining Core Values in Postgraduate Programs During the COVID-19 Pandemic von Persky, Adam M., Fuller, Kathryn A., Jarstfer, Michael, Rao, Kamakshi, Rodgers, Jo E., Smith, Megan

Volltext

Guideline‐Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure von Tran, Richard H., Aldemerdash, Ahmed, Chang, Patricia, Sueta, Carla A., Kaufman, Brystana, Asafu‐adjei, Josephine, Vardeny, Orly, Daubert, Eliza, Alburikan, Khalid A., Kucharska‐Newton, Anna M., Stearns, Sally C., Rodgers, Jo E.

Volltext

Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies von Veeder, Justin A., Hothem, Lauren N., Cipriani, Amber E., Jensen, Brian C., Rodgers, Jo E.

Volltext

Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure von Skersick, Preston T., Proco, Darrian, Sharma‐Huynh, Preetika, Montepara, Courtney A., Rodgers, Jo E.

Volltext

Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms von Miller, Abigail E, Montague, Deborah, Rodgers, Jo E, Sanghvi, Sonali, Whinna, Herbert C, Krumnacher, Heather

Volltext

Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (C... von Crespo, Eric M., MD, MPH, Oliveira, Gustavo B.F., MD, Honeycutt, Emily F., MBI, Becker, Richard C., MD, Berger, Peter B., MD, Moliterno, David J., MD, Anstrom, Kevin J., PhD, Abrams, Charles S., MD, Kleiman, Neal S., MD, Moll, Stephan, MD, Rice, Lawrence, MD, Rodgers, Jo E., PharmD, Steinhubl, Steven R., MD, Tapson, Victor F., MD, Granger, Christopher B., MD, Ohman, E. Magnus, MD

Volltext

Disparities by sex in P2Y 12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men... von Hickson, Ryan P, Kucharska-Newton, Anna M, Rodgers, Jo E, Sleath, Betsy L, Fang, Gang

Volltext